Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)

Rohto Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	813,087	676,888	631,946	421,488	336,849	337,648
Market Cap Growth	4.01%	7.11%	49.93%	25.13%	-0.24%	4.24%
Enterprise Value	784,797	610,616	575,682	380,505	296,984	300,704
Last Close Price	3564.00	2953.86	2736.12	1808.58	1431.32	1422.63
PE Ratio	26.89	21.85	23.73	19.69	19.56	21.12
PS Ratio	2.92	2.50	2.65	2.11	1.86	1.79
PB Ratio	3.15	2.74	2.94	2.29	2.15	2.41
P/FCF Ratio	-	25.77	28.15	24.82	29.84	25.10
P/OCF Ratio	-	19.77	20.44	15.47	16.84	17.73
EV/Sales Ratio	2.82	2.25	2.41	1.91	1.64	1.60
EV/EBITDA Ratio	16.13	12.50	13.93	10.61	10.38	10.08
EV/EBIT Ratio	19.75	15.20	17.17	13.50	13.58	13.14
EV/FCF Ratio	-	23.25	25.64	22.41	26.31	22.35
Debt / Equity Ratio	0.18	0.04	0.05	0.12	0.05	0.05
Debt / EBITDA Ratio	0.93	0.21	0.28	0.60	0.28	0.24
Debt / FCF Ratio	-	0.40	0.52	1.26	0.72	0.54
Asset Turnover	0.76	0.83	0.82	0.80	0.82	0.90
Inventory Turnover	2.21	2.59	2.71	2.71	2.55	2.43
Quick Ratio	1.18	1.82	1.75	1.74	1.79	1.54
Current Ratio	1.77	2.47	2.37	2.30	2.36	2.09
Return on Equity (ROE)	12.67%	13.59%	13.25%	12.42%	11.31%	11.23%
Return on Assets (ROA)	6.92%	7.66%	7.17%	7.04%	6.20%	6.87%
Return on Capital (ROIC)	9.32%	10.37%	9.70%	9.53%	8.76%	10.05%
Earnings Yield	3.72%	4.57%	4.17%	4.99%	4.97%	4.56%
FCF Yield	3.88%	3.55%	4.03%	3.35%	3.98%
Dividend Yield	0.93%	0.91%	0.80%	1.00%	0.98%	0.91%
Payout Ratio	0.00%	17.70%	17.73%	16.28%	17.71%	19.97%
Buyback Yield / Dilution	0.01%	0.00%	0.00%	-	-0.01%	0.00%
Total Shareholder Return	0.93%	0.91%	0.80%	1.00%	0.97%	0.92%

Source: S&P Capital IQ. Standard template. Financial Sources.